The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy

HGF/MET pathway mediates cancer initiation and development. Thus, inhibition on HGF-initiated MET signaling pathway would provide a new approach to cancer targeted therapeutics. In our study, we identified a targeting peptide candidate binding to HGF which was named HGF binding peptide-1 (HGP-1) via...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lisha, Li, Chunlin, Zhu, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745783/
https://www.ncbi.nlm.nih.gov/pubmed/26254225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745783/
https://www.ncbi.nlm.nih.gov/pubmed/26254225

Ejemplares similares